ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,547,000 | -5.8% | 285,100 | +3.7% | 0.01% | 0.0% |
| Q3 2016 | $3,765,000 | +80.1% | 275,000 | -2.8% | 0.01% | +100.0% |
| Q2 2016 | $2,090,000 | +15.2% | 282,800 | -3.9% | 0.00% | 0.0% |
| Q1 2016 | $1,814,000 | +23.5% | 294,200 | +25.2% | 0.00% | -25.0% |
| Q4 2015 | $1,469,000 | +7.1% | 235,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,372,000 | -18.6% | 235,000 | +15.3% | 0.00% | 0.0% |
| Q2 2015 | $1,686,000 | +2.2% | 203,900 | +1.8% | 0.00% | 0.0% |
| Q1 2015 | $1,650,000 | +22.5% | 200,300 | +2.2% | 0.00% | -20.0% |
| Q4 2014 | $1,347,000 | +27.3% | 196,000 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $1,058,000 | -15.3% | 196,000 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $1,249,000 | -24.3% | 196,000 | -4.3% | 0.01% | -16.7% |
| Q1 2014 | $1,651,000 | +53.9% | 204,900 | +30.2% | 0.01% | +50.0% |
| Q4 2013 | $1,073,000 | -62.9% | 157,400 | 0.0% | 0.00% | -66.7% |
| Q3 2013 | $2,896,000 | 0.0% | 157,400 | -5.0% | 0.01% | -7.7% |
| Q2 2013 | $2,896,000 | – | 165,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |